Librería: Basi6 International, Irving, TX, Estados Unidos de America
EUR 108,04
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Librería: Buchpark, Trebbin, Alemania
EUR 85,07
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Gut. Zustand: Gut | Sprache: Englisch | Produktart: Bücher | Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers ¿ based on the (known) pharmacology of the drug and/or biology of the underlying disease ¿ along with exposure¿response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.
Librería: Buchpark, Trebbin, Alemania
EUR 87,87
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers ¿ based on the (known) pharmacology of the drug and/or biology of the underlying disease ¿ along with exposure¿response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 225,68
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: preigu, Osnabrück, Alemania
EUR 184,85
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Appropriate Dose Selection - How to Optimize Clinical Drug Development | J. Venitz (u. a.) | Taschenbuch | Ernst Schering Foundation Symposium Proceedings | xvi | Englisch | 2014 | Springer | EAN 9783642421761 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 277,48
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Springer Berlin Heidelberg, 2006
ISBN 10: 3540278672 ISBN 13: 9783540278672
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 213,99
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers - based on the (known) pharmacology of the drug and/or biology of the underlying disease - along with exposure-response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 221,53
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers - based on the (known) pharmacology of the drug and/or biology of the underlying disease - along with exposure-response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 318,76
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Like New. Like New. book.
Publicado por Selbstverlag, 1991
Librería: Antiquariat Machte-Buch, Magdeburg, Alemania
EUR 14,00
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Broschur. 8° 1 Band 64 S. Ecken leicht bestoÃen, Einband leicht abgegriffen, sonst guter Zustand. Mit vielen Bildern.
Idioma: Inglés
Publicado por Springer Berlin Heidelberg Nov 2014, 2014
ISBN 10: 3642421768 ISBN 13: 9783642421761
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 123,04
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Optimal dose individualization has become more important in improving clinical efficacy and safety. This is due in part to the variability in drug response. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. This book reviews innovative methods, tools and examples of rational drug development strategies, particularly for novel oncological agents. 240 pp. Englisch.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 166,29
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: new. Questo è un articolo print on demand.
Idioma: Inglés
Publicado por Springer Berlin Heidelberg, 2014
ISBN 10: 3642421768 ISBN 13: 9783642421761
Librería: moluna, Greven, Alemania
EUR 180,07
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Reviews innovative methods, tools and examples of rational drug development strategies, particularly for novel oncological agentsOptimal dose individualization has become more important in improving clinical efficacy and safety, given the variability.
Idioma: Inglés
Publicado por Springer Berlin Heidelberg, 2006
ISBN 10: 3540278672 ISBN 13: 9783540278672
Librería: moluna, Greven, Alemania
EUR 180,07
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Reviews innovative methods, tools and examples of rational drug development strategies, particularly for novel oncological agentsOptimal dose individualization has become more important in improving clinical efficacy and safety, given the variability.
Idioma: Inglés
Publicado por Springer Berlin Heidelberg Okt 2006, 2006
ISBN 10: 3540278672 ISBN 13: 9783540278672
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 213,99
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Optimal dose individualization has become more important in improving clinical efficacy and safety. This is due in part to the variability in drug response. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. This book reviews innovative methods, tools and examples of rational drug development strategies, particularly for novel oncological agents. 240 pp. Englisch.
Librería: preigu, Osnabrück, Alemania
EUR 186,70
Cantidad disponible: 5 disponibles
Añadir al carritoBuch. Condición: Neu. Appropriate Dose Selection - How to Optimize Clinical Drug Development | J. Venitz (u. a.) | Buch | xvi | Englisch | 2006 | Springer | EAN 9783540278672 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Idioma: Inglés
Publicado por Springer, J.B. Metzler Nov 2014, 2014
ISBN 10: 3642421768 ISBN 13: 9783642421761
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 213,99
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers ¿ based on the (known) pharmacology of the drug and/or biology of the underlying disease ¿ along with exposure¿response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 240 pp. Englisch.
Idioma: Inglés
Publicado por Springer, Springer Okt 2006, 2006
ISBN 10: 3540278672 ISBN 13: 9783540278672
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 213,99
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Optimal dose individualization has become more important in improving clinical efficacy and safety, given the variability in drug response, e.g., due to concurrent illnesses or co-medications. Therefore, the role of optimal dose finding in early clinical drug development so as to maximize successful clinical use is emphasized. The continued use of biomarkers ¿ based on the (known) pharmacology of the drug and/or biology of the underlying disease ¿ along with exposure¿response evaluation throughout all phases of drug development can quantitatively integrate clinical pharmacology knowledge, provide early proof of concept, and help in rational dose selection and rational drug product labeling for clinical use.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 240 pp. Englisch.
Librería: Majestic Books, Hounslow, Reino Unido
EUR 296,72
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 294,39
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND.